MANISHA SHARMA: Open Payments
NPI 1720480023 · YUBA CITY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,059 in 46 payments from 18 companies in 2025. Trend: 2023 $795 · 2024 $1,112 · 2025 $1,059
Food & beverage: $1,059
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $143 |
| Novo Nordisk Inc | 5 | $126 |
| ViiV Healthcare Company | 2 | $126 |
| Teva Pharmaceuticals USA, Inc. | 3 | $116 |
| AstraZeneca Pharmaceuticals LP | 3 | $100 |
| PFIZER INC. | 2 | $56 |
| Daiichi Sankyo Inc. | 3 | $55 |
| ALK-Abello, Inc | 3 | $51 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| Exact Sciences Corporation | 2 | $43 |
Products named: APRETUDE, UZEDY, QULIPTA, BREZTRI, Rybelsus, PREVNAR 20, INJECTAFER, Kerendia.
Industry payments across CA — which companies pay providers there.
